fda tirzepatide update today https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound Important Notice: Tirzepatide Compounding Update

Consult your dermatologist if youre uncertain about treatment

Interestingly, theres research in JAMA Psychiatry to suggest that taking semaglutide (the medication in Ozempic and Wegovy) is associated with less drinking and craving for alcoholso reducing your intake may be easier when youre on a GLP-1

Molecules (Basel, Switzerland), 26(20), 6310

10.1097/00003086-199302000-00042 58 KawaiT.MiekiA.OhnoY.UmemuraM.KataokaH.KuritaS.et al (1993)

From a pharmaceutical perspective, this diversity introduces a level of chemical variability quite distinct from conventional active pharmaceutical ingredients, where composition is tightly controlled

The depletion of nuclear glutathione impairs cell proliferation in 3t3 fibroblasts